nicotine metabolism and smoking
Last edited 08/2018
- nicotine, the main addictive chemical in tobacco smoke, is essential to
continued and compulsive tobacco use
- when inhaled, nicotine is rapidly delivered to the systemic circulation
- once nicotine is in the bloodstream then it is distributed extensively to body tissues
- plasma half life of nicotine averages about 2 hours
- the vast majority of nicotine is metabolized in the liver by the
cytochrome P450 enzyme CYP2A6 (70-80%)
- nicotine is metabolized to cotinine, and cotinine is further
metabolized to 3'-hydroxycotinine (3HC) primarily by the liver
enzyme CYP2A6
- also, there is lesser metabolism of nicotine by other oxidative (CYP2B6 and CYP2D6) and non-oxidative pathways
- CYP2A6 is genetically polymorphic, individuals carrying inactive CYP2A6 alleles have decreased nicotine metabolism, are less likely to become smokers and if they do, they smoke fewer cigarettes per day
- nicotine is metabolized to cotinine, and cotinine is further
metabolized to 3'-hydroxycotinine (3HC) primarily by the liver
enzyme CYP2A6
- the vast majority of nicotine is metabolized in the liver by the
cytochrome P450 enzyme CYP2A6 (70-80%)
- when inhaled, nicotine is rapidly delivered to the systemic circulation
- oral contraceptive medications is known to increase nicotine metabolism
at CYP2A6
- in a study comparing the effects of valproate and carbamazepine on CYP2A6
actvity in patients with mental illness
- it was shown that carbamazepine but not valproate induces CYP2A6 activity
in smokers with mental illness (3)
- it was shown that carbamazepine but not valproate induces CYP2A6 activity
in smokers with mental illness (3)
- it is theorised that smokers with rapid nicotine metabolism might be expected
to smoke more intensely to compensate for the more rapid disappearance of
nicotine from the blood and brain, and may have more difficulty in quitting
smoking
Referernce:
- Hukkanen J, Jacob P, III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57:79-115
- Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd Clin Pharmacol Ther. 2006 May; 79(5):480-8.
- Williams JM et al. Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness. Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2582-9